Difference between revisions of "Manager Call 2016-06-1"

From GO Wiki
Jump to: navigation, search
(Identifier Space in GO Annotations)
(Identifier Space in GO Annotations)
Line 2: Line 2:
  
 
==Identifier Space in GO Annotations==
 
==Identifier Space in GO Annotations==
*In response to the May 18th call's discussion on gene and gene product identifier space (see [http://wiki.geneontology.org/index.php/Manager_Call_2015-05-18 minutes]), I've put together a spreadsheet that documents our current practice wrt for GAF and GPAd:
+
*In response to the May 18th call's discussion on gene and gene product identifier space (see [http://wiki.geneontology.org/index.php/Manager_Call_2015-05-18 minutes]), I've put together a [https://docs.google.com/spreadsheets/d/1mp1sZkxmpZbofaaG9qcAU_16l9S7jpzjnuwGvtSkeIA/edit#gid=1674924999 spreadsheet] that documents our current practice wrt for GAF and GPAD:
 
**Annotated Entity IDs
 
**Annotated Entity IDs
 
**With/From Entity IDs (note only for gene and gene product)
 
**With/From Entity IDs (note only for gene and gene product)
Line 10: Line 10:
 
**Gene IDs only
 
**Gene IDs only
 
**Broad range of gene, transcript, protein, protein complex entity IDs
 
**Broad range of gene, transcript, protein, protein complex entity IDs
 +
*At the top of the spreadsheet are three general questions that we need to consider - there may be more; please add if needed
 
*The plan was to review the different approaches, debate the pros and cons and then either get more feedback or finalize the proposal for presentation on an annotation or all-hands call
 
*The plan was to review the different approaches, debate the pros and cons and then either get more feedback or finalize the proposal for presentation on an annotation or all-hands call
  

Revision as of 07:44, 31 May 2016

Agenda

Identifier Space in GO Annotations

  • In response to the May 18th call's discussion on gene and gene product identifier space (see minutes), I've put together a spreadsheet that documents our current practice wrt for GAF and GPAD:
    • Annotated Entity IDs
    • With/From Entity IDs (note only for gene and gene product)
    • Annotation Extension Entity IDs (note only for gene and gene product)
    • Annotation Isoform Entity IDs
  • Then, for the purposes of discussion, I also added two other possible approaches:
    • Gene IDs only
    • Broad range of gene, transcript, protein, protein complex entity IDs
  • At the top of the spreadsheet are three general questions that we need to consider - there may be more; please add if needed
  • The plan was to review the different approaches, debate the pros and cons and then either get more feedback or finalize the proposal for presentation on an annotation or all-hands call

Periodic review of the Trello board

https://trello.com/b/IdtTLGEt/go-priorities

Minutes

Attendees:

Agenda: Paola; Minutes: Kimberly